ReviewClinical kidney journal2026
Blockchain technology for secure and efficient nephrology data management.
Review in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapid advancements in digital healthcare technologies have created new opportunities in nephrology, but they have also increased the fragmentation of datasets, complexity of data sharing, data privacy and security risks, and a lack of data verifiability and reliability (provenance). While several technological solutions have been developed to address these concerns individually, blockchain has been suggested as a unified solution for secure and efficient data management through several features. These include immutability, interoperability, and programmability, which provide a powerful framework that extends the utility of blockchain beyond data governance in nephrology. Blockchain also has potential applications in pharmaceutical and biobanking quality assurance and in the reliability of medical devices through auditable maintenance logs, making it a promising candidate to address several challenges in patient care and nephrology research. Despite this promise, practical challenges arise between the features of blockchain, such as immutability, and legislation, including the General Data Protection Regulation (GDPR). Furthermore, the value of real-world adoption in nephrology remains uncertain due to scalability, computational overheads, and implementation costs that may outweigh its advantages in many settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.